Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer Institute

Описание: Clip taken from "Genomic Medicine Meets Cancer Interception," presented Susan Domchek, MD. To watch the entire seminar, please visit:    • Stanford Cancer Institute Breakthroughs in...  

Susan Domchek, MD, is the Basser Professor in Oncology at the Perelman School of Medicine of the University of Pennsylvania. She serves as Executive Director of the Basser Center for BRCA at the Abramson Cancer Center and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Program.

Her work focuses on the genetic evaluation and medical management of individuals with inherited risk factors for cancer. Dr. Domchek is particularly interested in developing new cancer therapies, such as PARP inhibitors, for breast cancer due to genetic risk factors.

Breakthroughs in Cancer seminar series is one of the highest-profile seminar series for translational and clinical scientists in oncology. The series brings national leaders in cancer research to Stanford’s campus and highlights innovations across the spectrum of basic, translational, clinical, and population science. The series will be held in person on the second Tuesday of each month at Munzer Auditorium. #oncology #cancerresearch #breastcancer
Learn more about our Breakthroughs in Cancer seminar series: https://med.stanford.edu/cancer/train...
Learn more about the Stanford Cancer Institute: https://med.stanford.edu/cancer
Follow the Stanford Cancer Institute
LinkedIn:   / stanford-cancer  
Twitter:   / scidirector  
Subscribe to the Stanford Cancer Institute:    / @stanfordcancerinstitute